UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stock Position in Avantor, Inc. (NYSE:AVTR)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 3.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,087,216 shares of the company's stock after selling 298,638 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 1.19% of Avantor worth $209,216,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the stock. Canada Pension Plan Investment Board grew its position in Avantor by 6.8% in the 2nd quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company's stock worth $486,059,000 after purchasing an additional 1,463,695 shares during the period. 1832 Asset Management L.P. lifted its stake in shares of Avantor by 1,634.9% during the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company's stock valued at $180,839,000 after buying an additional 8,038,451 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in shares of Avantor by 653.0% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company's stock valued at $159,740,000 after buying an additional 5,354,678 shares in the last quarter. Robeco Schweiz AG lifted its stake in shares of Avantor by 5.0% during the 2nd quarter. Robeco Schweiz AG now owns 6,006,985 shares of the company's stock valued at $127,348,000 after buying an additional 287,717 shares in the last quarter. Finally, CCLA Investment Management lifted its stake in shares of Avantor by 8.7% during the 2nd quarter. CCLA Investment Management now owns 5,128,504 shares of the company's stock valued at $109,624,000 after buying an additional 408,360 shares in the last quarter. Institutional investors own 95.08% of the company's stock.

Avantor Stock Up 0.1 %

AVTR stock traded up $0.02 during trading on Friday, hitting $21.06. 3,337,532 shares of the company's stock traded hands, compared to its average volume of 6,860,813. The firm has a market capitalization of $14.33 billion, a P/E ratio of 45.78, a PEG ratio of 2.55 and a beta of 1.35. Avantor, Inc. has a 1 year low of $19.59 and a 1 year high of $28.00. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The business has a fifty day simple moving average of $23.28 and a two-hundred day simple moving average of $23.72.

Insider Buying and Selling at Avantor

In other news, CAO Steven W. Eck sold 3,525 shares of Avantor stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.50% of the stock is owned by insiders.

Analysts Set New Price Targets

Several brokerages have commented on AVTR. UBS Group decreased their price target on shares of Avantor from $30.00 to $29.00 and set a "buy" rating on the stock in a research note on Tuesday, October 8th. Robert W. Baird decreased their price target on shares of Avantor from $27.00 to $26.00 and set an "outperform" rating on the stock in a research note on Monday, October 28th. Barclays decreased their price target on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a research note on Friday, October 25th. Royal Bank of Canada reiterated an "outperform" rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. Finally, Wells Fargo & Company decreased their price target on shares of Avantor from $30.00 to $28.00 and set an "overweight" rating on the stock in a research note on Monday, October 28th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $27.57.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.